Anti-cancer agents and uses thereof
    24.
    发明授权
    Anti-cancer agents and uses thereof 失效
    抗癌剂及其用途

    公开(公告)号:US07504401B2

    公开(公告)日:2009-03-17

    申请号:US10928401

    申请日:2004-08-30

    摘要: The present invention is in the area of novel compounds and salts thereof, their syntheses, and their use as anti-cancer agents. The compounds include compounds of Formula I: and solvates, hydrates and pharmaceutically-acceptable salts thereof, wherein A1 is N or CR1; A3 is N or CR3; A5 is N or CR5; R1, R3-R6 and L are defined in the specification; n is 0 or 1; and X is an optionally-substituted aryl group having 6-10 carbons in the ring portion, an optionally-substituted 6-membered heteroaryl group having 1-3 nitrogen atoms in the ring portion, an optionally-substituted 5-membered heteroaryl group having 0-4 nitrogen atoms in the ring portion and optionally having 1 sulfur atom or 1 oxygen atom in the ring portion, or an optionally-substituted heteroaryl group in which a 6-membered ring is fused either to a 5-membered ring or to a 6-membered ring, wherein in each case 1, 2, 3 or 4 ring atoms are heteroatoms independently selected from nitrogen, oxygen and sulfur. They are effective against a broad range of cancers, especially leukemia, non-small cell lung and colon.

    摘要翻译: 本发明涉及新型化合物及其盐,其合成及其作为抗癌剂的用途。 化合物包括式I化合物及其溶剂合物,水合物及其药学上可接受的盐,其中A1为N或CR1; A3是N或CR3; A5为N或CR5; R1,R3-R6和L在说明书中定义; n为0或1; 并且X是在环部分中具有6-10个碳的任选取代的芳基,在环部分中具有1-3个氮原子的任选取代的6元杂芳基,任选取代的5元杂芳基具有0 -4个氮原子,并且在环部分中任选具有1个硫原子或1个氧原子,或任选取代的杂芳基,其中6元环稠合到5元环或6元环 其中在每种情况下,1,2,3或4个环原子是独立地选自氮,氧和硫的杂原子。 它们对广泛的癌症尤其是白血病,非小细胞肺和结肠有效。